| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 10.550 | 29.704 | 41.005 | 76.596 | 139.055 | 158.764 | 242.949 | 171.514 | 201.583 | 183.940 |
| Total Income - EUR | 10.549 | 29.719 | 41.005 | 76.596 | 139.140 | 161.430 | 242.969 | 171.725 | 201.586 | 183.940 |
| Total Expenses - EUR | 23.263 | 20.507 | 30.107 | 77.171 | 104.061 | 118.920 | 143.125 | 165.856 | 206.600 | 185.582 |
| Gross Profit/Loss - EUR | -12.714 | 9.212 | 10.898 | -575 | 35.079 | 42.510 | 99.844 | 5.869 | -5.014 | -1.642 |
| Net Profit/Loss - EUR | -13.030 | 8.400 | 9.905 | -1.341 | 33.688 | 40.983 | 97.705 | 4.237 | -7.031 | -7.160 |
| Employees | 1 | 1 | 1 | 3 | 4 | 6 | 4 | 4 | 4 | 4 |
Check the financial reports for the company - Biofocus Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 582 | 410 | 261 | 501 | 720 | 429 | 201 | 0 | 0 | 0 |
| Current Assets | 552 | 2.131 | 6.219 | 198 | 33.916 | 42.239 | 110.328 | 6.888 | 8.424 | 5.153 |
| Inventories | 389 | 1.122 | 767 | 6 | 0 | 0 | 0 | 501 | 0 | 0 |
| Receivables | 0 | 0 | 58 | 69 | 26.036 | 263 | 2.728 | 3.253 | 2.211 | 2.241 |
| Cash | 163 | 1.009 | 5.393 | 122 | 7.881 | 41.976 | 107.600 | 3.134 | 6.212 | 2.912 |
| Shareholders Funds | -12.963 | -4.431 | 5.549 | -1.264 | 32.448 | 41.057 | 109.125 | 4.765 | -2.280 | -9.428 |
| Social Capital | 67 | 67 | 66 | 64 | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | 14.097 | 6.972 | 930 | 1.963 | 4.058 | 1.612 | 1.404 | 2.123 | 10.704 | 14.580 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8559 - 8559" | |||||||||
| CAEN Financial Year |
8559
|
|||||||||
Comments - Biofocus Srl